HPI: The patient's mother contacted us regarding her daughter, a 28 yo woman with severe cystic acne for over three months. She has had acne in the past, but has also enjoyed long acne free periods as well. No recent changes in medications. The patient has a complicated medical and psychiatric history. She has had a diagnosis of bipolar illness disease (BPD) for greater than ten years. She has two children but her pregnancies were possibly complicated with hypercoagulation secondary to Protein S (history vague). She has been hospitalized for psychiatric disease. Presently, shes care for her children and is in school hoping to get a degree in social work. She is on a host of medications which include lithium, a mini OCP (progesterone only because estrogen is contraindicated due to Protein S). She is understandably depressed as a result of her acne.
O/E: The patient is a sad looking woman who sat in the waiting room with a baseball cap low on forehead and head bowed. She has cores of small to moderate cysts covering face. Back and chest clear. She is aesthenic.
Phtotos:
Labs: None yet
Questions:
It seems that periodically something triggers her acne. What are your thoughts?
Workup: Which serum androgens should be ordered? I am considering Total and Free Testosterone and DHEA-S.
Management: Since estrogenic OCPs are contraindicated and tetracyclines have interactions with lithium, what is best approach?
Lithium and progesterone both can cause acne flares. Do they act synergistically?
I started her on amoxicillin 500 mg tid until I get some better ideas.
There is a worrisome article on the use of isotretinoin in patients with BPD. (Ref 1) Do you believe this?
References:
1. Psychiatric reactions to isotretinoin in patients with bipolar disorder.
1. Psychiatric reactions to isotretinoin in patients with bipolar disorder.
Schaffer
LC, Schaffer CB, Hunter S, Miller A.
J Affect
Disord. 2010 May;122(3):306-8. doi: 10.1016/j.jad.2009.09.005.
Sutter
Community Hospitals, United States. schafferpsych@sbcglobal.net
Conclusions:
These results indicate that BD patients treated with isotretinoin for acne are
at risk for clinically significant exacerbation of mood symptoms, including
suicidal ideation, even with concurrent use of psychiatric medicines for BD.
The clinical implications of this study are especially relevant to the
treatment of patients with BD because acne usually occurs during adolescence,
which is often the age of onset of BD and because a common side effect of
lithium (a standard treatment for BD) is acne.
URL
2. [Retinoids:
drug interactions]. [Article in French]
Berbis P. Ann Dermatol Venereol. 1991;118(4):271-2.
Abstract There
is little available literature on possible drug interactions involving
retinoids despite their widespread use. Unlike some other molecules, the
retinoids regardless of their generation do not entail a high risk of
interference with other medications. A current study found that concomitant
administration of etretinate did not significantly modify the timing or value
of the peak serum level of 8 methoxy sporalene. Isotretinoin seems to have an
inhibiting effect on certain microsomal hepatic and cutaneous oxydases. An
isolated observation has been reported of reduced serum concentration of the
antiepileptic Carbamazepine in a patient treated with isotretinoin for severe
acne. The report, through unconfirmed, should prompt intensified monitoring of
patients receiving antiepileptics and retinoids. Among potential pharmacodynamic
interactions, studies with the most evident practical importance have assessed
possible interference of orally administered retinoids with the efficacy of
oral contraceptives (OCs). 1 study of isotretinoin and OCs concluded on the
basis of serum levels of progesterone on the 21st or 22nd cycle day that there
was no interference. Another study using the same evaluation criteria concluded
that there is no interaction between the aromatic retinoids etretinate or
acitretin and OCs. The use of low-dose progestins is however not recommended. A
recent study on healthy volunteers demonstrated the absence of influence of
acitretin on the efficacy of the antivitamin K agent phenprocoumon. The
combination of cyclines with isotretinoin can cause intracranial hypertension
and is formally contraindicated. Intracranial hypertension has also been
reported with aromatic retinoids, which are not recommended. The combination of
lithium and retinoids should also be avoided. Because of the additive effect of
undesirable side effects, the combination of retinoids and potentially
hepatotoxic molecules especially methotrexate and of isotretinoin and
potentially photosensitizing molecules should be avoided.. URL.
3. Is
thrombophilia testing useful?
Middeldorp
S.
Hematology
Am Soc Hematol Educ Program. 2011;2011:150-5. doi:
10.1182/asheducation-2011.1.150\
Department
of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.
Abstract: Thrombophilia
is found in many patients presenting with venous thromboembolism (VTE).
However, whether the results of such tests help in the clinical management of
such patients has not been determined. Thrombophilia testing in asymptomatic
relatives may be useful in families with antithrombin, protein C, or protein S
deficiency or homozygosity for factor V Leiden, but is limited to women who
intend to become pregnant or who would like to use oral contraceptives. Careful
counseling with knowledge of absolute risks helps patients in making an
informed decision in which their own preferences can be taken into account. Observational
studies show that patients who have had VTE and have thrombophilia are at most
at a slightly increased risk for recurrence. In an observational study, the
risk of recurrent VTE in patients who had been tested for inherited
thrombophilia was not lower than in patients who had not been tested. In the
absence of trials comparing routine and prolonged anticoagulant treatment in
patients testing positive for thrombophilia, testing for such defects to
prolong anticoagulant therapy cannot be justified. Diagnosing antiphospholipid
syndrome (APS) in women with recurrent miscarriage usually leads to treatment
with aspirin and low-molecular-weight heparin (LMWH), although the evidence to
support this treatment is limited. Because testing for thrombophilia serves a
limited purpose, this test should not be performed on a routine basis. Free
Full Text.
I agree with checking DHEAS and total Testosterone to look for androgen secreting tumors which are unlikely. As you pointed out, unopposed
ReplyDeleteprogesterone plus lithium are likely playing a role, though whether they are synergistic is not known to me.
Accutane is the treatment of choice and I would add an androgen receptor blocker (spironolactone) as well, starting with 50mg/day for a week, then 100mg/day, and possibly up to 150 if she tolerates it.
good luck
JCS